PJSC Polyus
PJSC Polyus (LSE, MOEX: PLZL) ( Polyus , the Company ) announces that an agreement for the supply of environmentally friendly electricity generated by the Sayano-Shushenskaya hydropower plant to Polyus Krasnoyarsk Business Unit ( KBU ) has been signed with PJSC RusHydro, a major Russian hydroelectricity supplier. The agreement assumes the provision of approximately 1 billion kWh of energy to KBU in 2021. Once supplies under this contract commence, 100% of the electricity consumed by Polyus largest producing assets, Olimpiada and Blagodatnoye, will be renewable. Based on this estimate, KBU expects to reduce greenhouse gas ( GHG ) emissions in 2021 by almost half, while company-wide GHG emissions may decrease by a third compared to the previous year. As a result, up to 90% of the electricity demand of the Company s operating assets will now be met by renewable sources.
DGAP-Ad-hoc: MagForce AG / Key word(s): Study
MagForce AG: MagForce USA, Inc. Announces Completion of Patient Treatment in Stage 2a of Pivotal U.S. Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System
08-Feb-2021 / 12:12 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Disclosure of an insider information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
MagForce AG: MagForce USA, Inc. Announces Completion of Patient Treatment in Stage 2a of Pivotal U.S. Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System
VEON and Mastercard enter into global partnership to boost digital financial services
Partnership to accelerate scaling of VEON s digital financial services business
News provided by
Share this article
Share this article
AMSTERDAM, Feb. 3, 2021 /PRNewswire/ VEON Ltd. (NASDAQ and Euronext Amsterdam: VEON), a leading global provider of connectivity and digital services, announces a strategic global partnership with payment technology leader Mastercard to boost digital financial services in key markets.
The partnership, covering core portions of VEON s footprint (Russia, Pakistan, Ukraine, Kazakhstan and Bangladesh), will allow VEON to further scale its digital financial services business by offering consumers and merchants in these countries best-in-class products tailored to their needs. By working together, the companies will support the financial and digital inclusion of traditionally underserved consumers in each geography.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Celyad Oncology Announces February 2021 Conference Schedule
Celyad Oncology SEFebruary 2, 2021 GMT
MONT-SAINT-GUIBERT, Belgium, Feb. 02, 2021 (GLOBE NEWSWIRE) Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company plans to participate at the following conferences in February 2021:
CAR-TCR Digital Summit Europe Time: 2:00 p.m. GMT / 3 p.m. CET
SVB Leerink Partners Global Healthcare Conference Date: Thursday, February 25, 2021 Time: 4:20 p.m. - 4:50 p.m. ET / 10:20 p.m. – 10:50 p.m. CET
Median overall survival and median progression free survival from the dose-escalation segment of the trial were 10.6 months and 3.9 months, respectively Tumor burden decrease observed in eight of 15 refractory unresectable mCRC patients, including six of nine patients at the highest dose level of 1x109 cells per inf.